Europe Insulin Delivery Devices Market Growth, Size, Trends, Revenue, Demand and Future Outlook

Europe Insulin Delivery Devices Market Size– By Type, By Application, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Europe Insulin Delivery Devices Market Size– By Type, By Application, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Feb 2024 Report ID: HLCA2418 Pages: 1 - 152 Formats*:     
Category : Healthcare
Europe Insulin Delivery Devices Market Introduction and Overview 

According to SPER Market Research, the Europe Insulin Delivery Devices Market is estimated to reach USD 3.54 billion by 2033 with CAGR of 3.19%.  

The report includes an in-depth analysis of the Europe Insulin Delivery Devices Market, including market size and trends, product mix, applications, and supplier analysis. All individuals with Type 1 and Type 2 diabetes fundamentally require insulin as part of their treatment regimen. The insulin delivery device is administered directly into the subcutaneous fatty tissues using insulin pens, syringes, insulin pumps, and jet injectors. More advanced insulin delivery devices have been developed as a result of the growing demand for minimally invasive administration methods, particularly in underserved areas of the globe.

  • April 2022: CamDiab and Ypsomed announced their collaboration to create and market an integrated automated insulin delivery (AID) system, which will enable diabetics in Europe manage their condition more easily
  • October 2022: Medtronic unveiled My Insights, a brand-new application designed specifically for users of the MiniMed 770G system. My Insights leverages the power of data science to deliver clients personalized suggestions, trends, and reminders to help them achieve their diabetes management objectives based on their particular data. 
Europe Insulin Delivery Devices Market
Market Opportunities and Challenges

The market for insulin delivery devices has grown as a result of a number of significant factors, including an increase in the number of people with diabetes, an increase in diabetes-related spending, collaboration between the public and private sectors to address diabetes needs, favourable insurance and reimbursement policies, and device insurance. Further contributing to the market's overall growth are variables like different government subsidies and advantageous reimbursement environments in particular nations, as well as the start of conferences, seminars, and congresses to raise awareness of insulin delivery devices. Profitable opportunities for the market are anticipated as a result of the sharp growth in R&D activity and healthcare spending. 

However, the market for insulin delivery devices is primarily being challenged by low adoption of insulin pumps, limited access to healthcare, and the availability of high-cost management in Europe. A patient may experience injury from an inappropriate insulin dosage. Furthermore, children under the age of eighteen are not allowed to use the devices. A significant obstacle facing the market is the quantity of insulin delivery devices that use short-acting insulin. The primary challenges that are thought to be impeding the market's growth are the inadequate reimbursement structure and the different problems associated with the reuse of pen needles and infusion sets. Additionally, the market's growth rate is hampered by the high costs of insulin delivery devices, the general lack of understanding of these devices' benefits, and the availability of substitute products.

Europe Insulin Delivery Devices Market


Market Competitive Landscape
Insulin delivery apparatuses the competitive landscape of the market offers information by rival. Overview of the company, financials, revenue, market potential, R&D investment, new market initiatives, presence in Europe, production facilities and capacities, company strengths and weaknesses are among the details included. Some of major players are Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others. 

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Type, By Application, By Distribution Channel, By End Use
 Regions covered
Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe

 Companies CoveredMedtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others.
COVID-19 Impact on Europe Insulin Delivery Devices Market
The COVID-19 pandemic had a major impact on the insulin delivery device market. COVID-19 affects patients with type 1 diabetes more frequently. When exposed to COVID-19, persons with diabetes rapidly decline due to their already weakened immune systems. Diabetes patients may be more vulnerable to serious issues than healthy people. Insulin delivery device makers have taken care to give these devices to diabetic patients during COVID-19, with help from local governments. Diabetes patients should exercise caution and check their blood sugar levels more frequently, according to medical professionals worldwide. A rise in medicine intake has led to an increase in the use of insulin delivery devices.

Key Target Audience:
  • Manufacturers and Suppliers
  • Healthcare Providers and Facilities
  • Pharmaceutical Companies
  • Patients and Caregivers
  • Health Insurance Companies
  • Regulatory Authorities
  • Research and Development Organizations
  • Academic Institutions
  • Patient Advocacy Groups
  • Investors and Financial Institutions
  • Government Health Departments
Our in-depth analysis of the Europe Insulin Delivery Devices Market includes the following segments:
By Type:
  • Insulin Jet Injectors
  • Insulin Pumps
  • Insulin Syringes
  • Pen Needles
  • By Application:
  • Type I Diabetes
  • Type II Diabetes
  • By Distribution Channel:
  • Diabetes Clinics
  • Hospital Pharmacy
  • Online Sales
  • Retail Pharmacy
  • By End Use:
  • Clinics
  • Homecare
  • Hospitals
  • Specialty Centres
  • Key Topics Covered in the Report:
    • Europe Insulin Delivery Devices  Market Size (FY’2023-FY’2033)
    • Overview of Europe Insulin Delivery Devices Market 
    • Segmentation of Europe Insulin Delivery Devices  Market By Type (Insulin Syringes, Insulin Jet Injectors, Pen Needles, Insulin Pumps)
    • Segmentation of Europe Insulin Delivery Devices  Market By Application (Type I Diabetes, Type II Diabetes)
    • Segmentation of Europe Insulin Delivery Devices Market By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics)
    • Segmentation of Europe Insulin Delivery Devices Market By End Use (Hospitals, Clinics, Homecare, Specialty Centres)
    • Statistical Snap of Europe Insulin Delivery Devices Market 
    • Expansion Analysis of Europe Insulin Delivery Devices Market 
    • Problems and Obstacles in Europe Insulin Delivery Devices Market 
    • Competitive Landscape in the Europe Insulin Delivery Devices Market 
    • Impact of COVID-19 and Demonetization on Europe Insulin Delivery Devices Market 
    • Details on Current Investment in Europe Insulin Delivery Devices Market 
    • Competitive Analysis of Europe Insulin Delivery Devices Market 
    • Prominent Players in the Europe Insulin Delivery Devices Market 
    • SWOT Analysis of Europe Insulin Delivery Devices Market 
    1.Introduction
    1.1.Scope of the report
    1.2.Market segment analysis

    2.Research Methodology
    2.1.Research data source
    2.1.1.Secondary Data
    2.1.2.Primary Data
    2.1.3.SPER’s internal database
    2.1.4.Premium insight from KOL’s
    2.2.Market size estimation
    2.2.1.Top-down and Bottom-up approach
    2.3.Data triangulation

    3.Executive Summary

    4.Market Dynamics
    4.1.Driver, Restraint, Opportunity and Challenges analysis
    4.1.1.Drivers
    4.1.2.Restraints
    4.1.3.Opportunities
    4.1.4.Challenges
    4.2.COVID-19 Impacts of the Europe Insulin Delivery Devices Market 

    5.Market variable and outlook
    5.1.SWOT Analysis
    5.1.1.Strengths
    5.1.2.Weaknesses
    5.1.3.Opportunities
    5.1.4.Threats
    5.2.PESTEL Analysis
    5.2.1.Political Landscape
    5.2.2.Economic Landscape
    5.2.3.Social Landscape
    5.2.4.Technological Landscape
    5.2.5.Environmental Landscape
    5.2.6.Legal Landscape
    5.3.PORTER’s Five Forces 
    5.3.1.Bargaining power of suppliers
    5.3.2.Bargaining power of buyers
    5.3.3.Threat of Substitute
    5.3.4.Threat of new entrant
    5.3.5.Competitive rivalry
    5.4.Heat Map Analysis

    6.Competitive Landscape
    6.1. Europe Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Application Type
    6.2.Mergers & Acquisitions, Partnerships, Type Launch, and Collaboration in Europe Insulin Delivery Devices Market 

    7.  Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
    7.1.  Europe Insulin Delivery Devices  Market Value Share and Forecast, By Type, 2023-2033
    7.2.Insulin Jet Injectors
    7.3.Insulin Pumps
    7.4.Insulin Syringes
    7.5.Pen Needles

    8.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)
    8.1.  Europe Insulin Delivery Devices  Market Value Share and Forecast, By Application, 2023-2033
    8.2.Type I Diabetes
    8.3.Type II Diabetes

    9.Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)
    9.1.  Europe Insulin Delivery Devices  Market Value Share and Forecast, By Distribution Channel, 2023-2033
    9.2.Diabetes Clinics
    9.3.Hospital Pharmacy
    9.4.Online Sales
    9.5.Retail Pharmacy

    10.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)
    10.1.  Europe Insulin Delivery Devices  Market Value Share and Forecast, By End Use, 2023-2033
    10.2.Clinics
    10.3.Homecare
    10.4.Hospitals
    10.5.Specialty Centres

    11.  Europe Insulin Delivery Devices  Market  Forecast, 2019-2033 (USD Million)
    11.1.  Europe Insulin Delivery Devices Market Size and Market Share

    12.Europe Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
    12.1. Europe Insulin Delivery Devices Market Size and Market Share By Type   (2019-2026)
    12.2. Europe Insulin Delivery Devices Market Size and Market Share By Type   (2027-2033)

    13.Europe Insulin Delivery Devices Market, By Application, 2019-2033 (USD Million)
    13.1. Europe Insulin Delivery Devices Market Size and Market Share By Application  (2019-2026)
    13.2. Europe Insulin Delivery Devices Market Size and Market Share By Application  (2027-2033)

    14.  Europe Insulin Delivery Devices Market, By Distribution Channel, 2019-2033 (USD Million)
    14.1.  Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel    (2019-2026)
    14.2.  Europe Insulin Delivery Devices Market Size and Market Share By Distribution Channel    (2027-2033)

    15.Europe Insulin Delivery Devices Market, By End Use, 2019-2033 (USD Million)
    15.1.  Europe Insulin Delivery Devices Market Size and Market Share By End Use   (2019-2026)
    15.2.  Europe Insulin Delivery Devices Market Size and Market Share By End Use  (2027-2033)

    16.  Europe Insulin Delivery Devices  Market, By Region, 2019-2033 (USD Million)
    16.1.  Europe Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
    16.2.  Europe Insulin Delivery Devices Market Size and Market Share By Region (2027-2033) 
    16.2.1.Belgium
    16.2.2.France
    16.2.3.Germany
    16.2.4.Italy
    16.2.5.Netherland
    16.2.6.Russia
    16.2.7.Spain
    16.2.8.Switzerland
    16.2.9.Turkey
    16.2.10.U.K.
    16.2.11.Rest of Europe

    17.Company Profile
    17.1.Abbott
    17.1.1.Company details
    17.1.2.Financial outlook
    17.1.3.Type summary 
    17.1.4.Recent developments
    17.2.Biocon
    17.2.1.Company details
    17.2.2.Financial outlook
    17.2.3.Type summary 
    17.2.4.Recent developments
    17.3.Eli Lily and Company
    17.3.1.Company details
    17.3.2.Financial outlook
    17.3.3.Type summary 
    17.3.4.Recent developments
    17.4.Johnson & Johnson Private Limited 
    17.4.1.Company details
    17.4.2.Financial outlook
    17.4.3.Type summary 
    17.4.4.Recent developments
    17.5.Medtronic
    17.5.1.Company details
    17.5.2.Financial outlook
    17.5.3.Type summary 
    17.5.4.Recent developments
    17.6.Tandem Diabetes Care Inc.
    17.6.1.Company details
    17.6.2.Financial outlook
    17.6.3.Type summary 
    17.6.4.Recent developments
    17.7.Others

    15List of Abbreviations

    16Reference Links

    17Conclusion

    18Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    The Europe is anticipated to have the highest market share in the Europe Insulin Delivery Devices Market.
    "The key players in the market include Companies Covered Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT and various others."
    A patient may experience injury from an inappropriate insulin dosage. Furthermore, children under the age of eighteen are not allowed to use the devices.
    Europe Insulin Delivery Devices Market is projected to reach USD 3.54 billion by 2033, growing at a CAGR of 3.19% during the forecast period.
    Europe Insulin Delivery Devices Market size from 2022. The Market is expected to reach USD 3.54 billion by 2033, at a CAGR of 3.19% during the forecast period.
    Europe Insulin Delivery Devices Market CAGR of 3.19% during the forecast period.
    Europe Insulin Delivery Devices Market size is 3.54 billion from 2023 to 2033.
    Europe Insulin Delivery Devices Market Segment is covered By Type, By Application, By Distribution Channel, By End Use.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-SIEMENS
    SPER-LOREAL
    SPER-Pfizer
    SPER-IPSOS
    SPER-Heineken
    SPER-IQVIA
    SPER-Kankar IMRB
    SPER-PWC

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650